21:28 EDT Cathie Wood’s ARK Investment buys 485K shares of Beam Therapeutics (BEAM) today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- JonesResearch upgrades Beam Therapeutics to Buy on de-risking data
- Beam Therapeutics upgraded to Buy from Hold at JonesResearch
- Beam data ‘encouraging,’ support continuation of trial, says H.C. Wainwright
- Promising Phase 1/2 Trial Results for Beam Therapeutics’ BEAM-302 Bolster Confidence and Support $80 Price Target
- Beam Therapeutics upgraded to Outperform from Sector Perform at Scotiabank
Questions or Comments about the article? Write to editor@tipranks.com